John P. Hamill
2018 - Cellectar Biosciences
In 2018, John P. Hamill earned a total compensation of $11.7K as Former Interim Chief Financial Officer at Cellectar Biosciences, a 93% decrease compared to previous year.
Compensation breakdown
Other | $11,742 |
---|---|
Total | $11,742 |
Hamill received $11.7K in other compensation, accounting for 100% of the total pay in 2018.
Rankings
In 2018, John P. Hamill's compensation ranked 14,212th out of 14,244 executives tracked by ExecPay.
Classification | Ranking | Percentile |
---|---|---|
All | 14,212 | 0th |
Manufacturing | 5,752 | 0th |
Chemicals And Allied Products | 2,120 | 0th |
Drugs | 1,809 | 0th |
Pharmaceutical Preparations | 1,384 | 0th |
Hamill's colleagues
We found four more compensation records of executives who worked with John P. Hamill at Cellectar Biosciences in 2018.
News
Aprea Therapeutics CFO John Hamill's 2023 pay jumps 62% to $908K
April 25, 2024
Discovery Laboratories CEO Craig Fraser's 2022 pay falls 50% to $941K
June 29, 2023
Discovery Laboratories CEO Craig Fraser's 2021 pay jumps 144% to $1.9M
May 11, 2022
Discovery Laboratories COO Eric Curtis receives $1.8M in 2020
April 30, 2021
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019